CellBion Co., Ltd. (KOSDAQ:308430)
37,700
-250 (-0.66%)
At close: Apr 28, 2026
CellBion Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,945 | 2,290 | 1,471 | 1,763 | 916.88 | Upgrade
|
| Revenue Growth (YoY) | -15.05% | 55.64% | -16.54% | 92.27% | -32.61% | Upgrade
|
| Cost of Revenue | 1,862 | 1,327 | 1,158 | 1,559 | 1,044 | Upgrade
|
| Gross Profit | 83.39 | 963.28 | 313.52 | 203.57 | -126.94 | Upgrade
|
| Selling, General & Admin | 3,235 | 2,711 | 1,968 | 2,443 | 2,017 | Upgrade
|
| Research & Development | 4,956 | 5,270 | 3,389 | 2,976 | 2,340 | Upgrade
|
| Other Operating Expenses | 136.31 | 118.08 | - | 87.86 | 66.61 | Upgrade
|
| Operating Expenses | 8,328 | 8,100 | 5,357 | 5,507 | 4,423 | Upgrade
|
| Operating Income | -8,245 | -7,137 | -5,043 | -5,303 | -4,550 | Upgrade
|
| Interest Expense | -137.03 | -535.88 | -140.18 | -352.51 | -276.8 | Upgrade
|
| Interest & Investment Income | 813.93 | 405.33 | 1,542 | 124.2 | 36.07 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.48 | - | - | -0.13 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -7.37 | -0.2 | 9.06 | -1,014 | 13.34 | Upgrade
|
| EBT Excluding Unusual Items | -7,574 | -7,267 | -3,633 | -6,546 | -4,778 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.03 | 1.29 | - | - | -0 | Upgrade
|
| Other Unusual Items | - | - | - | 164.1 | - | Upgrade
|
| Pretax Income | -7,574 | -7,266 | -3,633 | -6,382 | -4,778 | Upgrade
|
| Net Income | -7,574 | -7,266 | -3,633 | -6,382 | -4,778 | Upgrade
|
| Net Income to Common | -7,574 | -7,266 | -3,633 | -6,382 | -4,778 | Upgrade
|
| Shares Outstanding (Basic) | 13 | 10 | 10 | 10 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 10 | 10 | 10 | 9 | Upgrade
|
| Shares Change (YoY) | 26.24% | 2.27% | 2.28% | 10.36% | 1.48% | Upgrade
|
| EPS (Basic) | -591.00 | -715.78 | -366.00 | -657.64 | -543.34 | Upgrade
|
| EPS (Diluted) | -591.00 | -716.00 | -366.00 | -658.00 | -543.34 | Upgrade
|
| Free Cash Flow | -7,018 | -4,904 | -4,240 | -5,074 | -3,572 | Upgrade
|
| Free Cash Flow Per Share | -547.60 | -483.08 | -427.15 | -522.88 | -406.23 | Upgrade
|
| Gross Margin | 4.29% | 42.07% | 21.31% | 11.55% | -13.84% | Upgrade
|
| Operating Margin | -423.87% | -311.67% | -342.79% | -300.83% | -496.28% | Upgrade
|
| Profit Margin | -389.38% | -317.32% | -246.92% | -362.02% | -521.08% | Upgrade
|
| Free Cash Flow Margin | -360.79% | -214.16% | -288.18% | -287.84% | -389.58% | Upgrade
|
| EBITDA | -7,995 | -6,922 | -4,842 | -4,944 | -3,900 | Upgrade
|
| EBITDA Margin | - | - | - | -280.44% | - | Upgrade
|
| D&A For EBITDA | 249.4 | 215.01 | 201.75 | 359.53 | 650.52 | Upgrade
|
| EBIT | -8,245 | -7,137 | -5,043 | -5,303 | -4,550 | Upgrade
|
| Advertising Expenses | 9.91 | 5.27 | - | 7.57 | 7.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.